Filing Details

Accession Number:
0001567619-19-019301
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-07 16:21:07
Reporting Period:
2019-10-04
Accepted Time:
2019-10-07 16:21:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
70487 National Research Corp NRC Services-Commercial Physical & Biological Research (8731) 470634000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1654405 D. Steven Jackson C/O National Research Corporation
1245 Q Street
Lincoln NE 68508
President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-09-25 4,010 $59.15 89,586 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Employee Stock Option (Right to Buy) $15.23 2026-01-05 21,535 21,535 Direct
Common Stock Employee Stock Option (Right to Buy) $18.80 2027-01-04 17,608 17,608 Direct
Common Stock Employee Stock Option (Right to Buy) $36.80 2028-01-03 12,228 12,228 Direct
Common Stock Employee Stock Option (Right to Buy) $38.30 2029-01-03 11,749 11,749 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2026-01-05 21,535 21,535 Direct
2027-01-04 17,608 17,608 Direct
2028-01-03 12,228 12,228 Direct
2029-01-03 11,749 11,749 Direct
Footnotes
  1. The price in Column 4 is a weighted average price. The prices actually received ranged from $59.00 to $59.48. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
  2. This option becomes fully exercisable on January 5, 2021.
  3. This option becomes fully exercisable on January 4, 2022.
  4. This option becomes fully exercisable on January 3, 2023.
  5. This option becomes fully exercisable on January 3, 2024.